416
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

First-trimester screening for early preeclampsia risk using maternal characteristics and estimated placental volume

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1155-1160 | Received 07 Jan 2019, Accepted 02 Jun 2019, Published online: 20 Jun 2019

References

  • Ree PH , Hahn WB , Chang SW , et al. Early detection of preeclampsia using inhibin A and other second-trimester serum markers. Fetal Diagn Ther. 2011;29:280–286.
  • Bujold E , Roberge S , Lacasse Y , et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–414.
  • Roberge S , Villa P , Nicolaides K , et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31:141–146.
  • Koopmans CM , Bijlenga D , Groen H , et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009;374:979–988.
  • Horsager R , Roberts S. Williams obstetrics study guide. 24th ed. New York (NY): McGraw-Hill; 2015.
  • Timofeeva AV , Gusar VA , Kan NE , et al. Identification of potential early biomarkers of preeclampsia. Placenta 2018;61:61–71.
  • Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn. 2011;31:3–6.
  • Barrientos G , Pussetto M , Rose M , et al. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat. Mol Hum Reprod. 2017;23:509–519.
  • Rădulescu C , Bacârea A , Huțanu A , et al. Placental growth factor, Soluble fms-Like tyrosine kinase 1, Soluble endoglin, IL-6, and IL-16 as Biomarkers in preeclampsia. Mediators Inflamm. 2016;2016:1.
  • Pillay P , Moodley K , Moodley J , et al. Placenta-derived exosomes: potential biomarkers of preeclampsia. Ijn. 2017;12:8009–8023.
  • Livrinova V , Petrov I , Samardziski I , et al. Obstetric outcome in pregnant patients with low level of pregnancy-associated plasma protein A in first trimester. Open Access Maced J Med Sci. 2018;6:1028–1031.
  • Sonek J , Krantz D , Carmichael J , et al. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Am J Obstet Gynecol. 2018;218:126.e1–126.e13.
  • O’Gorman N , Wright D , Syngelaki A , et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol. 2016;214:103.e1–103.e12.
  • Committee on Obstetric Practice Society for Maternal–Fetal Medicine . ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44–e52.
  • Azpurua H , Funai EF , Coraluzzi LM , et al. Determination of placental weight using two-dimensional sonography and volumetric mathematic modeling. Amer J Perinatol. 2010;27:151–155.
  • Arleo EK , Troiano RN , da Silva R , et al. Utilizing two-dimensional ultrasound to develop normative curves for estimated placental volume. Amer J Perinatol. 2014;31:683–688.
  • Chen CY , Wang KG , Chen CP. Alteration of vascularization in preeclamptic placentas measured by three-dimensional power Doppler ultrasound. J Matern Fetal Neonatal Med. 2013;26:1616–1622.
  • Roberts JM , Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53–56.
  • Collins SL , Welsh AW , Impey L , et al. 3D fractional moving blood volume (3D-FMBV) demonstrates decreased first trimester placental vascularity in pre-eclampsia but not the term, small for gestation age baby. PLoS One 2017;12:e0178675.
  • Nicolaides KH. First-trimester screening for pre-eclampsia: time to act. Ultrasound Obstet Gynecol. 2017;50:663–664.
  • National Collaborating Centre for Women’s and Children’s Health . Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London (UK): Royal College of Obstetricians and Gynaecologists Press; 2010.
  • Bilano VL , Ota E , Ganchimeg T , et al. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One 2014;9:e91198.
  • Lee CJ , Hsieh TT , Chiu TH , et al. Risk factors for pre-eclampsia in an Asian population. Int J Gynecol Obstet. 2000;70:327–333.
  • Pourat N , Martinez AE , Jones JM , et al. Costs of gestational hypertensive disorders in California: hypertension, preeclampsia, and eclampsia. Los Angeles, (CA): UCLA Center for Health Policy Research; 2013.
  • Ortved D , Hawkins TL , Johnson JA , et al. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2019;53:239–244.
  • Roberge S , Giguère Y , Villa P , et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. 2012;29:551–556.
  • Tong S , Mol BW , Walker SP. Preventing preeclampsia with aspirin: does dose or timing matter? Am J Obstet Gynecol. 2017;216:95–97.
  • Lawrence JB , Oxvig C , Overgaard MT , et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA. 1999;96:3149–3153.
  • Almeida ST , Katz L , Coutinho I , et al. Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia. Int J Gynecol Obstet. 2017;138:142–147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.